Follow
Michele Carbone
Michele Carbone
Verified email at cc.hawaii.edu
Title
Cited by
Cited by
Year
Germline BAP1 mutations predispose to malignant mesothelioma
JR Testa, M Cheung, J Pei, JE Below, Y Tan, E Sementino, NJ Cox, ...
Nature genetics 43 (10), 1022-1025, 2011
9802011
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients
RM Flores, HI Pass, VE Seshan, J Dycoco, M Zakowski, M Carbone, ...
The Journal of thoracic and cardiovascular surgery 135 (3), 620-626. e3, 2008
6322008
BAP1 and cancer
M Carbone, H Yang, HI Pass, T Krausz, JR Testa, G Gaudino
Nature Reviews Cancer 13 (3), 153-159, 2013
5542013
Simian virus 40-like DNA sequences in human pleural mesothelioma.
M Carbone, HI Pass, P Rizzo, M Marinetti, M Di Muzio, DJ Mew, ...
Oncogene 9 (6), 1781-1790, 1994
5381994
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
Y Ohta, V Shridhar, RK Bright, GP Kalemkerian, W Du, M Carbone, ...
British journal of cancer 81 (1), 54-61, 1999
4861999
The pathogenesis of mesothelioma
M Carbone, RA Kratzke, JR Testa
Seminars in oncology 29 (1), 2-17, 2002
4692002
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
HI Pass, D Lott, F Lonardo, M Harbut, Z Liu, N Tang, M Carbone, C Webb, ...
New England Journal of Medicine 353 (15), 1564-1573, 2005
4582005
Malignant mesothelioma: facts, myths, and hypotheses
M Carbone, BH Ly, RF Dodson, I Pagano, PT Morris, UA Dogan, ...
Journal of cellular physiology 227 (1), 44-58, 2012
3892012
Cancer and inflammation: promise for biological therapy
S Demaria, E Pikarsky, M Karin, LM Coussens, YC Chen, EM El-Omar, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (4), 335, 2010
3822010
TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
H Yang, M Bocchetta, B Kroczynska, AG Elmishad, Y Chen, Z Liu, ...
Proceedings of the National Academy of Sciences 103 (27), 10397-10402, 2006
3212006
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
M Carbone, LK Ferris, F Baumann, A Napolitano, CA Lum, EG Flores, ...
Journal of translational medicine 10 (1), 1-7, 2012
3192012
Simian virus-40 large-T antigen binds p53 in human mesotheliomas
M Carbone, P Rizzo, PM Grimley, A Procopio, DJY Mew, V Shridhar, ...
Nature medicine 3 (8), 908-912, 1997
3151997
SV40 induces mesotheliomas in hamsters.
C Cicala, F Pompetti, M Carbone
The American journal of pathology 142 (5), 1524, 1993
3101993
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
I Roushdy-Hammady, J Siegel, S Emri, JR Testa, M Carbone
The Lancet 357 (9254), 444-445, 2001
3082001
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma
HI Pass, SM Levin, MR Harbut, J Melamed, L Chiriboga, J Donington, ...
New England Journal of Medicine 367 (15), 1417-1427, 2012
2972012
Benign and malignant mesothelioma.
KH Antman
Cancer: principles and practice of oncology, 1853-1878, 1997
297*1997
Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma
G Guo, J Chmielecki, C Goparaju, A Heguy, I Dolgalev, M Carbone, ...
Cancer research 75 (2), 264-269, 2015
2892015
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
A Bononi, C Giorgi, S Patergnani, D Larson, K Verbruggen, M Tanji, ...
Nature 546 (7659), 549-553, 2017
2852017
Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity
M Bocchetta, I Di Resta, A Powers, R Fresco, A Tosolini, JR Testa, ...
Proceedings of the National Academy of Sciences 97 (18), 10214-10219, 2000
2802000
Mesothelioma epidemiology, carcinogenesis, and pathogenesis
H Yang, JR Testa, M Carbone
Current treatment options in oncology 9 (2), 147-157, 2008
2782008
The system can't perform the operation now. Try again later.
Articles 1–20